ArticleMolecular cancer therapeutics2021

Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways.

Luigi Scotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.